The most common causes of heart disease involve cardiovascular risk factors like central obesity, hyperglycemia, hypertension and hyperlipidemia, which are pathogenically correlated. Our ingredient, Ankascin™ 568-R, which contains two major functional compounds – monascin and ankaflavin – has a positive impact on heart health.

Clinical studies on the INGREDIENT (www.ankascin.com) show that after 12 weeks of administration, fasting blood glucose was significantly reduced by 9.3%. It also reduced lipid accumulation caused by the high fat and fructose diet, lowering the induced blood glucose and insulin concentration. The clinically studied ingredient in Ankascin™ 568-R maintained insulin expression levels against methylglyoxal-induced damage to pancreatic tissues.

After 8 to 12 weeks of administration, cholesterol and LDL-C were significantly reduced by 11.1 % and 20.4 %. The clinical studies also revealed levels of good cholesterol were increased, levels of total cholesterol and bad cholesterol reduced, triglyceride levels reduced and evidently showed better effects on anti-atherosclerosis which is the hardening and narrowing of the arteries. Atherosclerosis silently and slowly blocks arteries, putting blood flow at risk. It is the usual cause of heart attacks, strokes and peripheral vascular disease - what together are called Cardiovascular Disease.

Clinical studies on blood pressure showed the systolic blood pressure decreased from 141.6 ± 12.0 to 133.9 ± 14.4 mmHg (P < 0.05), and diastolic blood pressure decreased from 91.7 ± 8.1 to 84.8 ± 7.4 mmHg (P < 0.05) after 8 weeks. More and more clinical studies on this active ingredient indicate that continuous administration of Ankascin™ 568-R can help reduce hypertensive symptoms and maintain healthy blood pressure.

A scientific study at University of Iowa suggested uses of Manuka honey in the prevention of heart disease related to bacterial infections. It is well known that the lethal effects of staphylococcal infective endocarditis, a bacterial infection which can cause the heart valves to stop working properly and kills approximately 20,000 Americans every year is really due to superantigens –toxins produced in very large quantities by Staphylococcus aureus (staph) bacteria. These bacterial toxins cause the immune system to break down and in the process lead to a debilitating and possibly fatal heart disease along with a host of other health concerns. Manuka honey has been used to treat staph bacteria and protect hearth from bacterial infections.
Coenzyme Q10 (CoQ10) has proven benefits specific to heart health, helping enhance blood flow, lower blood pressure and protect blood vessels, with the potential to reduce cardiovascular disease by reducing oxidative stress and maintaining optimal mitochondrial function in cardiac muscle cells. Uses of Ankascin™ 568-R with CoQ10 and unique New Zealand Manuka honey will provide good support for heart health.

• Ankascin™ 568-R - Help maintain healthy blood sugar, blood lipid and blood pressure.
• Manuka honey – Prevents heart from bacterial infection and maintains heart health.
• CoQ10 – Supports energy supply to the heart and reduces oxidative stress.

• Serving Size: 1 Sachet
• Serving Size per Container: 30
• AMOUNT PER SERVING*:
• Ankascin 568-R Patented Red Yeast Rice Extract: 110 mg (Monascin 3.1mg, Ankaflavin 1 mg)
• Manuka honey 150mg
• CoQ10 100mg

*Daily Value (DV) not established.